Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1453-1457

  Bingen, Edouard ^a   Fitoussi, Frederic ^a   Doit, Catherine ^a   Cohen, Robert ^b   Tanna, Asha ^c   George, Robert ^c   Loukil, Chawki ^a   Brahimi, Naima ^a   Le Thomas, Isabelle ^a   Deforche, Dominique ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; MIKAMYCIN B;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; FRANCE; GENE CLUSTER; NONHUMAN; PEDIATRICS; PRIORITY JOURNAL; RIBOTYPING; SEROTYPE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; FRANCE; HUMANS; INFANT; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0034118230     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1453-1457.2000     Document Type: Article

References (48)

1. Arpin, C., M. H. Canron, P. Noury, and C. Quentin. 1999. Emergence of mefA and mefE genes in beta-hemolytic streptococci and pneumococci in France. J. Antimicrob. Chemother. 44:133-134.
2. Baquero, F., J. A. García-Rodríguez, J. García De Lomas, L. Aguilar, and The Spanish Surveillance Group for Respiratory Pathogens. 1999. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. Antimicrob. Agents Chemother. 43:178-180.
3. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1997. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. J. Antimicrob. Chemother. 40:139-140.
4. Bingen, E., E. Denamur, N. Lambert-Zechovsky, C. Boissinot, N. Brahimi, Y. Aujard, P. Blot, and J. Elion. 1992. Mother-to-infant vertical transmission and cross-colonization of Streptococcus pyogenes confirmed by DNA restriction fragment length polymorphism analysis. J. Infect. Dis. 165:147-150.
5. Borzani, M., M. De Luca, and F. Varotto. 1997. A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy. J. Antimicrob. Chemother. 40:457-458.
6. Clancy, J., J. Petipas, F. Dib-Hajj, W. Yuan, M. Cronan, A. V. Kamath, J. Bergeron, and J. A. Retsema. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867-879.
7. α in a strain of Streptococcus pyogenes. Antimicrob. Agents Chemother. 5:534-537.
8. Cohen, R., A. Fremaux, A. de Gouvello, V. Deforche, C. Levy, D. Wadbled, F. de la Rocque, E. Varon, and P. Geslin. 1996. Sensibilité in vitro de souches de Streptococcus pyogenes récemment isolées d'angines communautaires. Med. Mal. Infect. 26:765-769.
9. Comité de l'Antibiogramme de la Société Française de Microbiologie. 1998. Pathol. Biol. 46:1-16.
10. Coonan, K. M., and E. L. Kaplan. 1994. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr. Infect. Dis. J. 13:630-635.
11. Cornaglia, G., M. Ligozzi, A. Mazzariol, L. Masala, G. Lo Cascio, G. Orefici, The Italian Surveillance Group for Antimicrobial Resistance, and R. Fontana. 1998. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin. Infect. Dis. 27(Suppl. 1):S87-S92.
12. de Azavedo, J. C. S., R. H. Yeung, D. J. Bast, C. L. Duncan, S. B. Borgia, and D. E. Low. 1999. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob. Agents Chemother. 43:2144-2147.
13. Doit, C., E. Denamur, B. Picard, P. Geslin, J. Elion, and E. Bingen. 1996. Mechanisms of the spread of penicillin in Streptococcus pneumoniae strains causing meningitis in children in France. J. Infect. Dis. 174:520-528.
14. Fischetti, V. A. 1989. Streptococcal M protein: molecular design and biological behavior. Clin. Microbiol. Rev. 2:285-314.
15. Fitoussi, F., K. Cohen, G. Brami, C. Doit, N. Brahimi, F. de la Rocque, and E. Bingen. 1997. Molecular DNA analysis for differentiation of persistence or relapse from recurrence in treatment failure of Streptococcus pyogenes pharyngitis. Eur. J. Clin. Microbiol. Infect. Dis. 16:233-237.
16. Fujita, K., K. Murono, M. Yoshikawa, and T. Murai. 1994. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr. Infect. Dis. J. 13:1075-1078.
17. Gerber, M. A. 1996. Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract. Pediatrics 97(Suppl.): 971-975.
18. Giovanetti, E., M. P. Montanari, M. Mingoia, and P. E. Varaldo. 1999. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibility-resistant strains. Antimicrob. Agents Chemother. 43:1935-1940.
19. Guillemot, D., P. Maison, C. Carbon, B. Balkau, F. Vauzelle-Kervroëdan, C. Sermet, G. Bouvenot, and E. Eschwège. 1998. Trends in antimicrobial drug use in the community between 1981 and 1992, in France. J. Infect. Dis. 177: 492-497.
20. Jasir, A., and C. Schalén. 1998. Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes. J. Antimicrob. Chemother. 41:135-137.
21. Kaplan, E. L. 1997. Recent evaluation of antimicrobial resistance in β-hemolytic streptococci. Clin. Infect. Dis. 24(Suppl. 1):S89-S92.
22. Kataja, J., P. Huovinen, M. Skurnik, The Finnish Study Group for Antimicrobial Resistance, and H. Seppala. 1999. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43:48-52.
23. Kataja, J., P. Huovinen, A. Muotiala, J. Vuopio-Varkila, A. Efstratiou, G. Hallas, The Finnish Study Group for Antimicrobial Resistance, and H. Seppälä. 1998. Clonal spread of group A Streptococcus with the new type of erythromycin-resistance. J. Infect. Dis. 177:786-789.
24. Klugman, K. P., T. Capper, C. A. Widdowson, H. J. Koornhof, and W. Moser. 1998. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. J. Antimicrob. Chemother. 42:729-734.
25. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
26. Lowbury, E. J. L. 1958. Symposium on epidemiological risks of antibiotics. Hospital infections. Proc. R. Soc. Med. 51:807-810.
27. Maruyama, S., H. Yoshioka, K. Fujita, M. Takimoto, and Y. Satake. 1979. Sensitivity of group A streptococci to antibiotics. Am. J. Dis. Child. 133: 1143-1145.
28. Miyamoto, Y., K. Takizawa, A. Matsushima, Y. Asai, and S. Nakatsuka. 1978. Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in pattern by type. Antimicrob. Agents Chemother. 13:399-404.
29. Nakae, M., T. Murai, Y. Kaneko, and S. Mitsuhashi. 1997. Drug resistance in Streptococcus pyogenes isolated in Japan (1974-1977). Antimicrob. Agents Chemother. 12:427-428.
30. National Committee for Clinical Laboratory Standards. 1998. Performance for antimicrobial susceptibility testing. Eighth informational supplement. M100 S8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
31. Observatoire national des prescriptions et consommations des médicaments dans les secteurs ambulatoire et hospitalier, and Agence du médicament, Direction des études et de l'information pharmaco-économiques. 1999. Prescription et consommation des antibiotiques en ambulatoire. Bull. Soc. Fr. Microbiol. 14:27-36.
32. Perez-Trallero, E., J. M. Marimon, J. M. Montes, B. Orden, and M. de Pablos. 1999. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg. Infect. Dis. 3:235-240.
33. Perez-Trallero, E., M. Urbieta, M. Montes, I. Ayestaran, and J. M. Marimon. 1998. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur. J. Clin. Microbiol. Infect. Dis. 17:25-31.
34. Sanders, E., M. T. Foster, and D. Scott. 1968. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N. Engl. J. Med. 278: 538-540.
35. Sanger, F., S. Nicklen, and A. R. Coulson. 1997. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
36. Seppäla, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.
37. Seppäla, H., T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenus, K. Lager, P. Huovinen, and the Finnish Study Group for Antimicrobial Resistance. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337:441-446.
38. Seppäla, H., T. Klaukka, R. Lehtonen, E. Nenonen, and P. Huovinen. 1997. Erythromycin resistance of group A streptococci from throat samples is related to age. Pediatr. Infect. Dis. J. 16:651-656.
39. Seppäla, H., T. Klaukka, R. Lehtonen, E. Nenonen, the Finnish Study Group for Antimicrobial Resistance, and P. Huovinen. 1995. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin. Infect. Dis. 21:1378-1385.
40. Seppälä, H., Q. He, M. Österblad, and P. Huovinen. 1994. Typing of group A Streptococci by random, amplified polymorphic DNA analysis. J. Clin. Microbiol. 32:1945-1948.
41. Seppälä, H., J. Vuopio-Varkila, M. Österblad, M. Jahkola, M. Rummukainen, S. E. Holm, and P. Huovinen. 1994. Evaluation of methods for epidemiologic typing of group A streptococci. J. Infect. Dis. 169:519-525.
42. Seppäla, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
43. Seppäla, H., A. Nissinen, H. Järvinen, S. Huovinen, T. Henriksson, E. Herva, E. Holm, M. Jahkola, M.-L. Katila, T. Klaukka, S. Kontiainen, O. Liimatainen, S. Oinonen, L. Passi-Metsomaa, and P. Huovinen. 1992 Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:292-297.
44. Sutcliffe, J., T. Grebe, A. Tait-Kamradl, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
45. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
46. Tzelepi, E., G. Kouppari, A. Mavroidi, A. Zaphiropoulou, and L. S. Tzouvelekis. 1999. Erythromycin resistance amongst group A β-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece. J. Antimicrob. Chemother 43:745-746.
47. Weisblum, B. 1995. Erythromycin resistance by rihosome modification. Antimicrob. Agents Chemother. 39:577-585.
48. York, M. K., L. Gibbs, F. Perdreau-Remington, and G. F. Brooks. 1999. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of Northern California. J. Clin. Microbiol. 37:1727-1731.